» Articles » PMID: 5388583

Behavioural and Somatic Effects of Bradykinin Injected into the Cerebral Ventricles of Unanaesthetized Rabbits

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1969 Nov 1
PMID 5388583
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

1. The effects of bradykinin (1-5 mug) injected into the cannulated lateral cerebral ventricles were studied in unanaesthetized rabbits before and after intravenous atropine, diphemanil and morphine.2. The intraventricular injections of bradykinin produced a short-lasting phase of behavioural excitation with vocalization followed by sedation. The behavioural excitation was associated with desynchronization in the electrocorticogram (e.co.g.), bradycardia and hypotension followed by tachycardia and hypertension. Tachypnoea was also observed. The subsequent phase of sedation was more prolonged and associated with synchronization of the e.co.g. and signs of catalepsy. Intense miosis was present during both phases.3. With repeated intraventricular injections of bradykinin, excitation, miosis, cardiovascular responses and tachypnoea diminished and eventually disappeared but the sedation did not exhibit tachyphylaxis.4. Atropine abolished the e.co.g. desynchronization, vocalization and bradycardia, reduced the duration of the excitatory and sedatory phase, diminished the tachycardia and hypotension, enhanced the hypertension, but did not affect the miosis and tachypnoea.5. Diphemanil affected only the cardiovascular effects produced by intraventricular bradykinin. They were affected in the same way as by atropine.6. Morphine did not affect the excitatory phase, but enhanced the cardiovascular effects produced by intraventricular bradykinin.7. The intraventricular injection of bradykinin (50 mug) caused a reduction in the amount of noradrenaline but not of 5-hydroxytryptamine (5-HT) in the brain stem; the amount of dopamine in the caudate nuclei was not affected.8. It is suggested that central cholinergic and adrenergic systems are activated by intraventricular bradykinin.

Citing Articles

Thermal biology in Brazil: a summary of a 100-year legacy.

Muller-Ribeiro F, Griggio M, Luz J, Coimbra C Temperature (Austin). 2016; 2(4):441-6.

PMID: 27227059 PMC: 4843943. DOI: 10.1080/23328940.2015.1120045.


Inhibition of acute nociceptive responses in rats after i.c.v. injection of Thr6-bradykinin, isolated from the venom of the social wasp, Polybia occidentalis.

Mortari M, Cunha A, Carolino R, Coutinho-Netto J, Tomaz J, Lopes N Br J Pharmacol. 2007; 151(6):860-9.

PMID: 17533426 PMC: 2014116. DOI: 10.1038/sj.bjp.0707275.


Central B2 receptor involvement in the antinociceptive effect of bradykinin in rats.

Pela I, Rosa A, Silva C, Huidobro-Toro J Br J Pharmacol. 1996; 118(6):1488-92.

PMID: 8832076 PMC: 1909663. DOI: 10.1111/j.1476-5381.1996.tb15564.x.


Introduction to the actions of kinins and prostaglandins.

COLLIER H Proc R Soc Med. 1971; 64(1):1-4.

PMID: 4994578 PMC: 1811929.


Intraventricular infusions in acute and chronic rabbits. Application of the stereotaxic method of Monnier and Gangloff.

Monnier M, Hatt A Pflugers Arch. 1970; 317(3):268-77.

PMID: 4910211 DOI: 10.1007/BF00586508.


References
1.
Carlsson A, Lindqvist M, Magnusson T . 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 1957; 180(4596):1200. DOI: 10.1038/1801200a0. View

2.
Carpi A, PINTO CORRADO A . Cerebral vascular action of bradykinin in the dog. Experientia. 1961; 17:326-7. DOI: 10.1007/BF02158185. View

3.
Ferreira S . A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA. Br J Pharmacol Chemother. 1965; 24:163-9. PMC: 1704050. DOI: 10.1111/j.1476-5381.1965.tb02091.x. View

4.
Elliott D, Horton E, Lewis G . Actions of pure bradykinin. J Physiol. 1960; 153:473-80. PMC: 1359764. DOI: 10.1113/jphysiol.1960.sp006548. View

5.
Banerjee U, Burks T, FELDBERG W, Goodrich C . Temperature effects and catalepsy produced by morphine injected into the cerebral ventricles of rabbits. Br J Pharmacol Chemother. 1968; 33(3):544-51. PMC: 1570252. DOI: 10.1111/j.1476-5381.1968.tb00503.x. View